You're reading the free version. Trader adds the live tape and alerts.
Start tracking
QNCX Award Disclosure
Roberts Brigette · SEC Form 4 · Filed Jun 11, 2026
Award
Reported value range
Not reported
Roberts Brigette Chief Corp. Affairs Officer
QNCX
Quince Therapeutics
QNCX
Transaction date
May 18, 2026
Public filing date
Jun 11, 2026
Filing lag
Filed 24 days later
QNCX daily price context
Close on/before transaction
$0.99
May 18, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Employee Stock Option (Right to Buy) on Common Stock
- Quantity / price
- 2,070,107 shares
- SEC ownership
- Direct
- Transaction code
- A
- Form
- 4
- Filing identifier
- 0001346566-26-000004
Filing cohort
Transactions in this filing
Showing 9 of 9
Trades
9
Issuers
1
Estimated value
Not reported
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Quince Therapeutics, Inc. QNCX | Award | May 18, 2026 | Not reported |
| Quince Therapeutics, Inc. QNCX | Award | May 18, 2026 | Not reported |
| Quince Therapeutics, Inc. QNCX | Award | May 18, 2026 | Not reported |
| Quince Therapeutics, Inc. QNCX Current | Award | May 18, 2026 | Not reported |
| Quince Therapeutics, Inc. QNCX | Award | May 18, 2026 | Not reported |
| Quince Therapeutics, Inc. QNCX | Award | May 18, 2026 | Not reported |
| Quince Therapeutics, Inc. QNCX | Award | May 18, 2026 | Not reported |
| Quince Therapeutics, Inc. QNCX | Award | May 18, 2026 | Not reported |
| Quince Therapeutics, Inc. QNCX | Award | May 18, 2026 | Not reported |